Navigation Links
The very defensive caterpillar

Caterpillars are bleeding defensive! Insects are known to lack an antibody-mediated immune response, and research in caterpillars has recently shown that, instead, they produce protective proteins in response to bacterial infection. The pattern recognition receptors (PRR) and antibacterial effectors produced at a first infection still function to protect against a repeated challenge. These results raise important issues in insect research which will be reported by Dr. Ioannis Eleftherianos at the Society of Experimental Biology Annual Meeting at the Universitat Autonoma de Barcelona on Wednesday 13th of July.

After being fed on a diet of antibiotics, hawkmoth (Manduca sexta) caterpillars were infected by non-pathogenic bacteria (E. coli), followed by exposure to a second, but lethal insect pathogen (Photorhabdus). Investigation of their blood then showed that antibacterial peptides were being produced by the so-called 'fat-body', an organ specialised in protein production. These proteins appear to be able to persist from the initial benign E. coli infection and then confer resistance against the second, usually lethal, infection by the pathogen. Using RNAi techniques workers at the University of Bath have shown that several different proteins can confer this protective effect against subsequent infections.

Micro-organisms such as bacteria, fungi and nematodes are often used as biocontrol agents against insects. It had always been assumed that insects in the field would be naïve to such control agents but these results raise the possibility that control with one pathogen may confer resistance to another. Most experiments on insect immunity are conducted in the laboratory on insects often fed on antibiotic containing diet so these results suggest that the immune response of insect constantly exposed to pathogens in the field may be very different from all the work described in the laboratory. This raises new challenges for the field and places into ques tion the relevance of laboratory based studies on immunity.


'"/>

Source:Society for Experimental Biology


Related biology news :

1. Nonvenomous Asian snakes borrow defensive poison from toxic toads
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/1/2017)... BOSTON, Massachusetts , February 1, 2017 ... and events on emerging technology, announces the availability of a new ... Continue Reading ... ... systems in industrial and collaborative robots. Source: IDTechEx Report "Sensors for ...
(Date:1/30/2017)... 30, 2017   Invitae Corporation (NYSE: ... information companies, today announced that it will report its ... 2017 guidance on Monday, February 13, 2017, and Invitae,s ... at 4:45 p.m. Eastern / 1:45 p.m. Pacific. ... briefly review financial results, guidance, and recent developments and ...
(Date:1/26/2017)... , Jan. 26, 2017  Acuity Market ... for Biometrics and Digital Identity".  Acuity characterizes 2017 ... identity when increased adoption reflects a new understanding ... "Biometrics and digital identity are often ... Maxine Most , Principal of Acuity Market ...
Breaking Biology News(10 mins):
(Date:2/20/2017)... 20, 2017  Atrius Health and IBM (NYSE: ... agreement to develop a cloud based service designed ... holistic view of the multiple influences on an ... could be designed to support shared decision making ... innovative nonprofit healthcare organization with 875 physicians caring ...
(Date:2/18/2017)... 18, 2017 Kurzlehrgang mit ... adoptiven Zelltherapie-Studien, Poster legt metaproteomische Analyse des Darm-Mikrobioms bei ... ... wird Dr. Yoav Peretz , Scientific Director bei ... von Assays zum Nachweis intrazellulärer Zytokine bei adoptiven Zelltherapie-Studien ...
(Date:2/18/2017)... ... February 17, 2017 , ... A leader in ... Kong. , Nerium International is proud to introduce its Age-Defying Night Cream, NeriumAD™ ... Formula to consumers across Hong Kong. The luxury skincare products contain innovative ingredients ...
(Date:2/17/2017)... February 17, 2017 According ... by Product (Consumables, Service), Type (Safety, Efficacy, Validation), ... Drug Discovery and Development, Disease-Risk) - Global Forecast ... projected to reach USD 53.34 Billion by 2021 ... a CAGR of 13.8% during the forecast period ...
Breaking Biology Technology: